Jazz Pharmaceuticals plc (JAZZ)

Jazz Pharmaceuticals plc holds an AlphaScore of 49/100 within the Healthcare sector, priced at 218.42. Key performance indicators feature a high gross margin of 91.35% alongside a negative return on equity of -8.25%. A notable strength is its value sub-score of 77, while a primary risk is reflected in its negative net margin of -8.35%. Evidence is limited to this record's snapshot date of 2026-10-11.

Written 11/10/2026, 00:41:00 UTC · Snapshot 11/10/2026